DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Singulair (Montelukast) - Adverse Event Reports - Serious Event - Headache

 



Index of reports > Cases resulting in a serious event (378) > Cases with Headache (28)

Below is the selection of adverse event reports related to Singulair (Montelukast) that includes cases resulting in a serious event where reactions include headache.

 Reports 1 - 25 of 28   Next >>

Adverse event in male receiving Singulair (Montelukast)

Reported by a consumer/non-health professional from United States on 2007-10-18

Patient: male

Adverse reactions / side effects: Asthma, Drug Ineffective, Restlessness, Insomnia, Headache, Sinusitis

Suspect drug(s):
Advair Diskus 100 / 50
    Dosage: 1puff twice per day
    Indication: Asthma
    Start date: 2001-01-01

Loratadine
    Dosage: 10mg per day
    Administration route: Oral
    Indication: Multiple Allergies
    Start date: 2006-07-01

Mometasone Furoate
    Dosage: 2spr per day
    Indication: Multiple Allergies
    Start date: 2006-07-01

Singulair
    Dosage: 10mg per day
    Administration route: Oral
    Indication: Multiple Allergies
    Start date: 2006-07-01



Adverse event in 8 year old female receiving Singulair (Montelukast)

Reported by a consumer/non-health professional from United States on 2007-10-04

Patient: 8 year old female

Adverse reactions / side effects: Vomiting, Headache

Adverse event resulted in: disablity

Suspect drug(s):
Advair Diskus 100 / 50
    Dosage: 2puff twice per day
    Indication: Asthma
    Start date: 2007-01-01

Singulair
    Dosage: 5mg per day
    Administration route: Oral
    Indication: Asthma
    Start date: 2005-01-01
    End date: 2007-06-01

Other drugs received by patient: Spiriva; Zyrtec; Intal; Albuterol



Adverse event in 6 year old male receiving Singulair (Montelukast)

Reported by a consumer/non-health professional from United States on 2007-07-26

Patient: 6 year old male, weighing 29.0 kg (63.8 pounds)

Adverse reactions / side effects: Hallucination, Auditory, Dyskinesia, Abasia, Headache, Constipation, Feeling Cold, Malaise, Fatigue, Anger, Aura, Migraine, Nightmare, Clonus, Muscular Weakness, Flushing, Arthralgia, Hallucination, Visual, Diarrhoea, Ear Pain, Parosmia, Complex Partial Seizures, Athetosis

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Singulair (Montelukast)

Other drugs received by patient: Albuterol



Adverse event in 51 year old female receiving Singulair (Montelukast)

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2007-07-19

Patient: 51 year old female

Adverse reactions / side effects: Haemorrhage, Headache

Suspect drug(s):
Singulair (Montelukast)

Other drugs received by patient: Fluticasone Propionate and Salmeterol Xinafoate; Cilazapril; Ipratropium Bromide; Albuterol Sulfate; Paroxetine Hydrochloride



Adverse event in 6 year old male receiving Singulair (Montelukast)

Reported by a physician from United States on 2007-07-16

Patient: 6 year old male, weighing 29.0 kg (63.8 pounds)

Adverse reactions / side effects: Hallucination, Auditory, Dyskinesia, Headache, Constipation, Feeling Cold, Fatigue, Anger, Aura, Migraine, Nightmare, Clonus, Muscular Weakness, Convulsion, Flushing, Hallucination, Visual, Diarrhoea, Arthralgia, Parosmia, Athetosis

Adverse event resulted in: hospitalization

Suspect drug(s):
Singulair (Montelukast)

Other drugs received by patient: Albuterol



Adverse event in 36 year old male receiving Singulair (Montelukast)

Reported by a physician from Germany on 2007-06-29

Patient: 36 year old male, weighing 78.0 kg (171.6 pounds)

Adverse reactions / side effects: Speech Disorder, Dysaesthesia, Headache

Adverse event resulted in: hospitalization

Suspect drug(s):
Singulair (Montelukast)

Other drugs received by patient: Albuterol Sulfate; Budesonide



Adverse event in 36 year old female receiving Singulair (Montelukast)

Reported by a physician from Norway on 2007-06-08

Patient: 36 year old female

Adverse reactions / side effects: Listless, Joint Swelling, Nausea, Oedema Peripheral, Dizziness, Headache, Pyrexia

Adverse event resulted in: disablity

Suspect drug(s):
Singulair
    Administration route: Oral
    Indication: Asthma
    Start date: 2007-02-01
    End date: 2007-04-20

Singulair
    Administration route: Oral
    Indication: Rhinitis Allergic
    Start date: 2007-02-01
    End date: 2007-04-20



Adverse event in 11 year old male receiving Singulair (Montelukast)

Reported by a physician from France on 2007-05-24

Patient: 11 year old male

Adverse reactions / side effects: Malaise, Fatigue, Headache

Adverse event resulted in: hospitalization

Suspect drug(s):
Singulair (Montelukast)

Other drugs received by patient: Cetirizine Hydrochloride



Adverse event in 9 year old female receiving Singulair (Montelukast)

Reported by a consumer/non-health professional from United States on 2007-05-17

Patient: 9 year old female, weighing 31.8 kg (69.9 pounds)

Adverse reactions / side effects: Vomiting, Nausea, Headache, Crying

Suspect drug(s):
Singulair (Montelukast)



Adverse event in 65 year old female receiving Singulair (Montelukast)

Reported by a physician from Poland on 2007-05-15

Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)

Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Pruritus, Bone Pain, Petechiae, Cerebrovascular Disorder, Headache, Somnolence, Generalised Oedema, Hypercholesterolaemia, Myalgia, Fatigue, Face Oedema, Chest Pain, DRY Mouth, Conjunctival Hyperaemia, Oedema Peripheral, Abdominal Distension, Dizziness, Depression, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Autonomic Nervous System Imbalance, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Syncope, Arthralgia, Feeling Abnormal

Adverse event resulted in: life threatening event, hospitalization, disablity

Suspect drug(s):
Singulair
    Administration route: Oral
    Indication: Rhinitis Allergic
    Start date: 2004-11-01
    End date: 2006-06-01

Singulair
    Administration route: Oral
    Indication: Asthma
    Start date: 2004-11-01
    End date: 2006-06-01

Other drugs received by patient: Levothyroxine Sodium; Quinapril Hydrochloride; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Aspirin; Aspirin; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil



Adverse event in 65 year old female receiving Singulair (Montelukast)

Reported by a physician from Poland on 2007-05-11

Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)

Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Pruritus, Bone Pain, Petechiae, Cerebrovascular Disorder, Headache, Somnolence, Generalised Oedema, Hypercholesterolaemia, Myalgia, Fatigue, Face Oedema, Chest Pain, DRY Mouth, Conjunctival Hyperaemia, Oedema Peripheral, Abdominal Distension, Dizziness, Depression, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Autonomic Nervous System Imbalance, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Arthralgia, Feeling Abnormal

Adverse event resulted in: life threatening event, hospitalization, disablity

Suspect drug(s):
Singulair
    Administration route: Oral
    Indication: Rhinitis Allergic
    Start date: 2004-11-01
    End date: 2006-06-01

Singulair
    Administration route: Oral
    Indication: Asthma
    Start date: 2004-11-01
    End date: 2006-06-01

Other drugs received by patient: Levothyroxine Sodium; Quinapril Hydrochloride; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Aspirin; Aspirin; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil



Adverse event in 5 year old female receiving Singulair (Montelukast)

Reported by a physician from Netherlands on 2007-04-09

Patient: 5 year old female

Adverse reactions / side effects: Confusional State, Movement Disorder, Prescribed Overdose, Headache

Adverse event resulted in: hospitalization

Suspect drug(s):
Singulair (Montelukast)

Other drugs received by patient: Fluticasone Propionate; Albuterol



Adverse event in 9 year old male receiving Singulair (Montelukast)

Reported by a physician from Poland on 2007-03-06

Patient: 9 year old male, weighing 30.0 kg (66.0 pounds)

Adverse reactions / side effects: Pain in Extremity, Headache

Adverse event resulted in: hospitalization

Suspect drug(s):
Singulair
    Administration route: Oral
    Indication: Asthma
    Start date: 2006-02-07
    End date: 2006-02-09

Singulair
    Administration route: Oral
    Start date: 2006-02-17
    End date: 2006-02-19



Adverse event in 47 year old female receiving Singulair (Montelukast)

Reported by a consumer/non-health professional from United States on 2007-03-05

Patient: 47 year old female

Adverse reactions / side effects: Asthma, Blood Pressure Increased, Headache

Adverse event resulted in: hospitalization

Suspect drug(s):
Singulair
    Administration route: Oral
    Indication: Asthma
    Start date: 2002-01-01

Singulair
    Administration route: Oral
    End date: 2007-02-27

Other drugs received by patient: Advair Diskus 100 / 50



Adverse event in 10 year old male receiving Singulair (Montelukast)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-03-02

Patient: 10 year old male

Adverse reactions / side effects: Irritability, Vertigo, Headache, Thirst, Aggression

Suspect drug(s):
Singulair
    Indication: Asthma
    Start date: 2005-09-23
    End date: 2005-10-23

Singulair
    Administration route: Oral
    Start date: 2006-11-15
    End date: 2007-02-13

Other drugs received by patient: Fluticasone Propionate; Albuterol; Salmeterol



Adverse event in female receiving Singulair (Montelukast)

Reported by a consumer/non-health professional from United States on 2007-02-26

Patient: female

Adverse reactions / side effects: Osteoporosis, Musculoskeletal Pain, Headache, Joint Stiffness, Body Height Decreased, Upper Respiratory Tract Infection, Throat Irritation, Bone Density Decreased, Candidiasis, Cough

Adverse event resulted in: hospitalization

Suspect drug(s):
Advair Diskus 100 / 50
    Dosage: 1puff twice per day
    Indication: Chronic Obstructive Pulmonary Disease

Singulair

Other drugs received by patient: Albuterol; Nebulizer



Adverse event in 65 year old female receiving Singulair (Montelukast)

Reported by a physician from Poland on 2007-02-20

Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)

Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Pruritus, Bone Pain, Petechiae, Cerebrovascular Disorder, Headache, Somnolence, Generalised Oedema, Hypercholesterolaemia, Myalgia, Fatigue, Face Oedema, Chest Pain, DRY Mouth, Conjunctival Hyperaemia, Oedema Peripheral, Abdominal Distension, Dizziness, Depression, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Autonomic Nervous System Imbalance, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Arthralgia, Feeling Abnormal

Adverse event resulted in: life threatening event, hospitalization, disablity

Suspect drug(s):
Singulair
    Administration route: Oral
    Indication: Rhinitis Allergic
    Start date: 2004-11-01
    End date: 2006-06-01

Singulair
    Administration route: Oral
    Indication: Asthma
    Start date: 2004-11-01
    End date: 2006-06-01

Other drugs received by patient: Levothyroxine Sodium; Quinapril Hydrochloride; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Aspirin; Aspirin; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil



Adverse event in 65 year old female receiving Singulair (Montelukast)

Reported by a physician from Poland on 2007-02-19

Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)

Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Pruritus, Bone Pain, Petechiae, Cerebrovascular Disorder, Headache, Somnolence, Generalised Oedema, Myalgia, Face Oedema, Fatigue, DRY Mouth, Chest Pain, Conjunctival Hyperaemia, Oedema Peripheral, Abdominal Distension, Dizziness, Depression, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Arthralgia, Feeling Abnormal

Adverse event resulted in: life threatening event, hospitalization, disablity

Suspect drug(s):
Singulair
    Administration route: Oral
    Indication: Rhinitis Allergic
    Start date: 2004-11-01
    End date: 2006-06-01

Singulair
    Administration route: Oral
    Indication: Asthma
    Start date: 2004-11-01
    End date: 2006-06-01

Other drugs received by patient: Levothyroxine Sodium; Quinapril Hydrochloride; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Aspirin; Aspirin; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil



Adverse event in 36 year old male receiving Singulair (Montelukast)

Reported by a physician from Germany on 2007-02-13

Patient: 36 year old male, weighing 78.0 kg (171.6 pounds)

Adverse reactions / side effects: Speech Disorder, Dysaesthesia, Headache

Adverse event resulted in: hospitalization

Suspect drug(s):
Singulair (Montelukast)

Other drugs received by patient: Albuterol Sulfate; Budesonide



Adverse event in 65 year old female receiving Singulair (Montelukast)

Reported by a physician from Poland on 2007-02-09

Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)

Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Petechiae, Headache, Somnolence, Generalised Oedema, Myalgia, Fatigue, Chest Pain, DRY Mouth, Abdominal Distension, Dizziness, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Arthralgia, Feeling Abnormal

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Singulair
    Administration route: Oral
    Indication: Rhinitis Allergic
    Start date: 2004-11-01
    End date: 2006-06-01

Singulair
    Administration route: Oral
    Indication: Asthma
    Start date: 2004-11-01
    End date: 2006-06-01

Other drugs received by patient: Aspirin; Levothyroxine Sodium; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil



Adverse event in 8 year old female receiving Singulair (Montelukast)

Reported by a physician from Japan on 2007-02-08

Patient: 8 year old female, weighing 26.0 kg (57.2 pounds)

Adverse reactions / side effects: Nausea, Dizziness, Thirst, Headache, Asthenia, Pallor

Suspect drug(s):
Singulair (Montelukast)

Other drugs received by patient: Packera Aurea; Ethyl Cysteine Hydrochloride; Ambroxol Hydrochloride; Tulobuterol; Intal



Adverse event in 44 year old male receiving Singulair (Montelukast)

Reported by a individual with unspecified qualification from France on 2007-02-07

Patient: 44 year old male, weighing 61.0 kg (134.2 pounds)

Adverse reactions / side effects: Vomiting, Hypothermia, Alanine Aminotransferase Increased, Rhinitis, Headache, Hyperhidrosis, Transaminases Increased, Gamma-Glutamyltransferase Increased, Aspartate Aminotransferase Increased, Miosis, Photophobia, Dizziness, Bradycardia, Salivary Hypersecretion, Cholinergic Syndrome

Adverse event resulted in: hospitalization

Suspect drug(s):
Depakene
    Dosage: 500 mg, tid
    Administration route: Oral
    Indication: Epilepsy
    Start date: 1996-01-01

Urbanyl
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Epilepsy
    Start date: 1996-01-01

Kenzen
    Dosage: 4 mg, qd
    Administration route: Oral
    Start date: 2004-01-01

Singulair
    Dosage: 10 mg, qd
    Administration route: Oral
    Start date: 2004-01-01

Desloratadine
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Rhinitis
    Start date: 2006-11-17
    End date: 2006-11-23

Tegretol
    Dosage: 400 mg, tid
    Administration route: Oral
    Indication: Epilepsy
    Start date: 1996-01-01



Adverse event in 36 year old male receiving Singulair (Montelukast)

Reported by a physician from Germany on 2007-02-02

Patient: 36 year old male, weighing 78.0 kg (171.6 pounds)

Adverse reactions / side effects: Speech Disorder, Dysaesthesia, Headache

Adverse event resulted in: hospitalization

Suspect drug(s):
Singulair (Montelukast)

Other drugs received by patient: Albuterol Sulfate; Budesonide



Adverse event in 36 year old male receiving Singulair (Montelukast)

Reported by a physician from Germany on 2007-01-30

Patient: 36 year old male, weighing 78.0 kg (171.6 pounds)

Adverse reactions / side effects: Speech Disorder, Dysaesthesia, Headache

Adverse event resulted in: hospitalization

Suspect drug(s):
Singulair (Montelukast)

Other drugs received by patient: Albuterol Sulfate; Budesonide



Adverse event in 44 year old male receiving Singulair (Montelukast)

Reported by a individual with unspecified qualification from France on 2007-01-26

Patient: 44 year old male, weighing 61.0 kg (134.2 pounds)

Adverse reactions / side effects: Hypothermia, Alanine Aminotransferase Increased, Rhinitis, Headache, Hyperhidrosis, Transaminases Increased, Gamma-Glutamyltransferase Increased, Aspartate Aminotransferase Increased, Miosis, Dizziness, Bradycardia, Salivary Hypersecretion, Cholinergic Syndrome

Adverse event resulted in: hospitalization

Suspect drug(s):
Depakene
    Dosage: 500 mg, tid
    Administration route: Oral

Urbanyl
    Dosage: 5 mg, qd
    Administration route: Oral

Kenzen
    Dosage: 4 mg, qd
    Administration route: Oral

Singulair
    Dosage: 10 mg, qd
    Administration route: Oral

Desloratadine
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Rhinitis
    Start date: 2006-11-17
    End date: 2006-11-23

Tegretol
    Dosage: 400 mg, tid
    Administration route: Oral



 Page 1   Next >>

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009